B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray

Human Pathology

Volumn 39, Issue 6, 2008, Pages 817-823

  Tumwine, Lynnette K ^a   Campidelli, Cristina ^b   Righi, Simona ^b   Neda, Sophia ^b   Byarugaba, Wilson ^a   Pileri, Stefano A ^b  

^a MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Burkitt lymphoma; Non Hodgkin lymphoma; Phenotype; Tissue microarray; Uganda

Indexed keywords

CD30 ANTIGEN; SYNDECAN 1;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL DIFFERENTIATION; CELL STRUCTURE; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHATIC SYSTEM TUMOR; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MORPHOLOGY; TISSUE MICROARRAY; UGANDA;

ADOLESCENT; ADULT; ANTIGENS, CD30; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DNA, NEOPLASM; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PLASMA CELLS; RNA, VIRAL; SYNDECAN-1; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UGANDA;

EID: 44649146378     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.10.025     Document Type: Article

References (34)

1. Tzankov A., Went P., Zimpfer A., and Dirnhofer S. Tissue micro array technology: principles, pitfalls and perspectives-lessons learned from hematological malignancies. Exp Gerontol 40 (2005) 737-744
2. Jaffe E., Harris N.L., Stein H., and Vardiman J.W. World Health Organization Classification of tumors. Pathology and genetics of tumors of the haemopoietic and lymphoid tissues (2001), IARC Press, Lyon
3. Zettl A., Meister S., Katzenberge T., et al. Immunohistochemical analysis of B cell lymphoma using tissue micro arrays identifies particular phenotypic profiles of B cell lymphomas. Histopathology 43 (2003) 209-219
4. Milanes-Yearsley M., Hammond M.E., Pajak T.F., et al. Tissue micro array: a cost and time effective method for correlative studies by regional and national cancer study groups. Mod Pathol 15 (2002) 1366-1373
5. Lazzi S., Ferrari F., Nyongo A., et al. HIV-associated malignant lymphomas in Kenya (Equatorial Africa). Hum Pathol 29 (1998) 1285-1289
6. Cool C., and Bitter M. The malignant lymphomas of Kenya; morphology, immunophenotype, and frequency of EBV in 73 cases. Hum Pathol 28 (1997) 1026-1033
7. Kasili E., and Bowry T. Malignant lymphoma in Kenya: pattern and pathology (excluding Burkitt's lymphoma). East Afr Med J 54 (1977) 480-490
8. Ogada T. Malignant lympho-reticular diseases at Kenyatta National Hospital in 1973. East Afr Med J 51 (1974) 824-828
9. Pileri S.A., Roncador G., Ceccarelli C., et al. Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol 183 (1997) 116-123
10. Sabattini E., Bisgaard K., Ascani S., et al. Envision Plus: a new immunohistochemical method of choice for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC and SABC techniques. J Clin Pathol 51 (1998) 506-511
11. Naish S. Handbook-Immunohistochemical staining methods (1989), DAKO Corporation, Carpenteria
12. SPSS Inc. Statistical analysis software. Chicago, IL.
13. Striener D., and Norman G. A practical guide to development and use of health measurement scales (1995), University Press, Oxford
14. Zinzani P.L., Dirnhofer S., Sabattini E., et al. Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro arrays. Haematologica 90 (2005) 341-347
15. Parkin D.M., Garcia-Giannoli H., Raphael M., et al. Non Hodgkin lymphoma in Uganda: a case-control study. AIDS 14 (2000) 2929-2936
16. Camilleri-Broet S., Criniere E., Broet P., et al. A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood 107 (2006) 190-196
17. Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 46 (1958) 218-223
18. Tumwine L., Wabinga H., and Odida M. Haematoxylin and eosin staining in the diagnosis of Hodgkin's disease in Uganda. East Afr Med J 80 (2003) 119-123
19. Olweny C. Diseases of children in the tropics and subtropics (1991), Replika Press Pvt Ltd, Narela, Delhi
20. Spina D., Leoncini L., Megha T., et al. Cellular kinetic and phenotypic heterogeneity in and among Burkitt's and Burkitt-like lymphomas. J Pathol 182 (1997) 145-150
21. Hummel M., Bentink S., Berger H., et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profile. N Engl J Med 354 (2006) 2419-2430
22. Guedez L., Martinez A., Zhao S., et al. Tissue inhibitor of metalloproteinase1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt-lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors. Blood 105 (2005) 1660-1688
23. Mbulaiteye S.M., Katabira E.T., Wabinga H., et al. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118 (2006) 985-990
24. Newton R., Ziegler J., Beral V., et al. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer 92 (2001) 622-627
25. Davidson A., Desai F., Hendricks M., et al. The evolving management of Burkitt's lymphoma at Red Cross Children's Hospital. S Afr Med J 96 (2006) 950-954
26. Van den Bosch C. Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter. Lancet Oncol 5 (2004) 738-746
27. Klein G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci U S A 76 (1979) 2442-2446
28. Lam K.M., Syed N., Whittle H., and Crawford D.H. Circulating Epstein-Barr-carrying B-cells in acute malaria. Lancet 337 (1991) 876-878
29. Moormann A.M., Chelimo K., Sumba P.O., et al. Exposure to Holoendemic malaria results in suppression of Epstein-Barr virus-specific T-cell immunosurveillance in Kenyan children. J Infect Dis 195 (2007) 799-808
30. Silva A.C., deFaria D.E., Borges N.B., et al. Toxicological screening of Euphorbia tirucalli L., Developmental toxicological studies in rats. J Ethnopharmacol 110 (2007) 154-159
31. MacNeil A., Sumba O.P., and Lutzke M. Activation of the Epstein-Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli. Br J Cancer 88 (2003) 1566-1569
32. Imai S., and Hukuda S. African Burkitt's lymphoma: a plant, Euphorbia tirucalli, reduces Epstein-Barr virus-specific cellular immunity. Anticancer Res 14 (1994) 933-936
33. Wabinga H., Parkin D.M., Wabwire-Mangen F., and Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 82 (2000) 1585-1592
34. Camacho F., Garcia J.F., Cigudosa J.C., et al. Aberrant Bcl-6 protein expression in mantle cell lymphoma. Am J Surg Pathol 28 (2004) 1051-1056